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TYROSINE PHOSPHORYLATION EVENTS IN MOUSE SPERM CAPACITATION 
 
 
 
Mammalian sperm are not able to fertilize immediately upon ejaculation; they become 
fertilization-competent after undergoing changes in the female reproductive tract 
collectively termed capacitation. Although it has been established that capacitation is 
associated with an increase in tyrosine phosphorylation, little is known about the role of 
this event in sperm function. In this work we used a combination of two dimensional gel 
electrophoresis and mass spectrometry to identify proteins that undergo tyrosine 
phosphorylation during capacitation. Some of the identified proteins are the mouse 
orthologues of human sperm proteins known to undergo tyrosine phosphorylation. 
Among them we identified VDAC, tubulin, PDH E1 β chain, glutathione S-transferase, 
NADH dehydrogenase (ubiquinone) Fe-S protein 6, acrosin binding protein precursor 
(sp32), proteasome subunit alpha type 6b and cytochrome b-c1 complex. In addition to 
 vii 
previously described proteins, we identified two testis-specific aldolases as substrates for 
tyrosine phosphorylation. Genomic and EST analyses suggest that these aldolases are 
retroposons expressed exclusively in the testis, as has been reported elsewhere. Because 
of the importance of glycolysis for sperm function, we hypothesize that tyrosine 
phosphorylation of these proteins can play a role in the regulation of glycolysis during 
capacitation. However, neither the Km nor the Vmax of aldolase changed as a function of 
capacitation when its enzymatic activity was assayed in vitro, suggesting other levels of 
regulation for aldolase function.  Looking upstream the kinase cascade, the identity of the 
 kinase (s) that brings about the phosphorylation of the tyrosine residues remains to be 
elucidated.  It has been suggested that the non receptor tyrosine kinase Src family is 
involved in the capacitation associated phosphorylation cascade.   Using an 
immunological approach we show that the only Src family member present in mouse 
sperm extract is Src.  The capacitation associated tyrosine phosphorylation is greatly 
reduced in the presence of Src specific inhibitors (SU6656 and SKI606)  in vivo.  As a 
means of control for the activity of Src inhibitors in our system, parallel experiments 
assaying the activity of PKA both in vivo and in vitro were realized.  Surprisingly, Src 
inhibitors down regulates the phosphorylation of serine/threonine residues that correlate 
on earlier events in the capacitation, as assayed by western blot with PKA substrates 
antibody.  However, in vitro kinase activity of PKA showed no effect of Src inhibitors in 
the phosphorylation of the PKA specific substrate, kemptide.    
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CHAPTER I 
MOUSE SPERM CAPACITATION SIGNALING  
 
Sperm physiology  
 
The term sperm is derived from the Greek word (σπέρµα) sperma (meaning 
"seed") and refers to the male reproductive cells.  Sperm are very specialized, terminally 
differentiated cells with the unique function of protecting and delivering the genetic 
material to the next generation.  This unique role is supported by the sperm degree of 
compartmelization and unique cellular structures.   Like its female counterpart, the 
oocyte, sperm cell cycle remains arrested until the male achieves puberty.  At this point 
the systemic testosterone levels trigger the resumption of the sperm cell cycle and 
maturation. 
During sperm differentiation, named spermatogenesis, round germ cells 
undergoes a dramatic transformation (Yanagimachi 1994).    The mature sperm contains 
the head, middle piece and the flagellum.  The head contains the nucleus with densely 
condensed chromatin and the acrosome, anterior to the head (Fig 1).  The acrosome is a 
specialized organelle that contains digestive enzymes that upon contact with the oocyte 
are released to break down the protective zona pellucida of the ovum.  Posterior to the 
head is the mid piece, during spermatogenesis mitochondria are fused forming the 
mitochondrial sheat.  
The sperm flagellum is a substructure that endows the sperm with motility 
capability.  The flagellar axoneme (Fig 2.) consists of 9 double sets of microtubules 
surrounding a central double set of microtubules (9x2+2) arrangement, characteristics of 
 2 
eukaryotic flagella.  Dynein arms are attached to the outer microtubule doubles, 
providing the motor force to propel the sperm. 
 
 
 
 
 
 
 
 
 
 
 
 
Sperm Capacitation 
 
Upon ejaculation mammalian sperm lack fertilizing ability.  In order to be able to 
fertilize sperm need to undergo a maturational process inside the female reproductive 
tract.  It involves a series of biochemical and biophysical events that were first described 
by two independent laboratories at the beginning of the 1950’s (Austin 1951; Chang 
1951).  These changes occur both in the head (preparation for acrosome reaction) and in 
the tail (change in pattern of motility from progressive to hyperactivated).   
The foundation of assisted reproductive technologies was established by the 
pioneering work of Yanagimachi and Chang. In these two articles, using hamster sperm, 
Figure 2 Structure of the flagellar 
axoneme 
Figure 1 Sperm sub cellular structures 
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they successfully performed the first documented mammalian sperm capacitation in vitro.  
Since then, the signaling pathways that trigger sperm capacitation had been extensively 
researched, and although much had been learned, the mechanisms are still far from fully 
elucidated (Salicioni et al. 2007). 
Capacitation occurs in a time dependent manner  (Yanagimachi 1994), while the 
sperm travels through the female reproductive tract. The time requirements for this 
process are species specific.  Defined media containing energy substrates as pyruvate, 
lactate and glucose, a cholesterol acceptor, and an ionic environment mainly constituted 
by NaHCO3, Ca2+, K+ and Na2+ have been successfully used to mimic capacitation in 
vitro.  The ability of sperm to fertilize an egg is the initial definition and still the most 
important evidence of capacitation. However, capacitation has also been described using 
other functional assays and endpoints related to physiological changes in both sperm head 
and tail. These events include hyperpolarization, a tight regulation in intracellular ion 
concentrations and the promotion of tyrosine residues phosphorylation of a subset of 
proteins (Visconti et al. 2002).  Moreover, the sperm plasma membrane of the 
capacitating sperm surface has an increased disordering of the fatty acid chains of the 
phospholipids and enhanced lateral fluidity probably due to lose of membrane cholesterol 
(Harrison 1996; Gadella and Harrison 2000; Harrison et al. 2000; Visconti et al. 2002). 
 
Phosphorylation Of Tyrosine Residues Associated  
With Sperm Capacitation 
 
As sperm becomes terminally differentiated, it loses the translational machinery; 
therefore, regulation of protein function relies on cell signaling events. Among these, 
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tyrosine phosphorylation is one of the most characterized post translational 
modifications. The events that bring about sperm capacitation can be subdivided 
temporally into slow and fast events (Salicioni et al. 2007; Visconti 2009) (Fig. 3).  
Despite of the difference in dynamics, both slow and fast events are mediated through the 
cyclic AMP dependent serine/threonine kinase PKA.  Upon contact with an isotonic 
solution containing HCO3-  and Ca2+, which coordinate the stimulation of a atypical 
soluble adenylyl cyclase (SACY), the flagellar movement show vigorous activation.  It is 
believed that the transport is mediated by a Na+/HCO3- co transporter (NBC) and a sperm 
specific calcium channel (CatSper).  
 
Until recently, however, the majority of the research in sperm capacitation has 
been focused on slow occurring events (Salicioni et al. 2007).  These slow events give 
Figure 3 Slow and fast events involved in sperm capacitation.  Fast events are triggered 
upon contact with bicarbonate and calcium.  Longer incubation in a capacitation 
conducive media elicits the fertilizing ability that is correlated with an increase of 
tyrosine phosphorylated proteins. 
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rise to the verifiable endpoints of capacitation status. These endpoints are: 1) increase of 
tyrosine phosphorylation, 2) hyperactivation of sperm motility and, 3) readiness to 
undergo the acrosome reaction.   
The phosphorylation of tyrosine residues have been shown to correlate with the 
capacitated state in several mammalian species (Visconti et al. 1995; Leclerc et al. 1996; 
Galantino-Homer et al. 1997; Kulanand and Shivaji 2001).  Since the fertilizing 
competence of sperm involves the activation of kinase cascades, the characterization of 
proteins undergoing phosphorylation upon capacitation would help to assess how these 
changes promote the acquisition of fertilizing capacity.  Some of the protein that have 
been identified as differentially phosphorylated in tyrosine residues upon capacitation in 
mammals are: two members of the PKA anchoring proteins, AKAP 3 (Ficarro et al. 
2003), AKAP 4 (Jha and Shivaji 2002) , FSP95, a 95 kD fibrous sheat protein (Mandal et 
al. 1999), dihydrolipoamide dehydrogenase (DLD) (Mitra and Shivaji 2004), heat shock 
protein 90 (Ecroyd et al. 2003), valosin containing protein (p97) (Ficarro et al. 2003), a 
calcium binding tyrosine phosphorylated protein from the fibrous sheat (CABYR) 
(Naaby-Hansen et al. 2002), the mitochondrial phospholipid hydroperoxidase glutathione 
peroxidase (Nagdas et al. 2005) and pyruvate dehydrogenase E1 α  (Kumar et al. 2008) 
and E1 β (Ficarro et al. 2003), among others.   
Looking upstream the signaling cascade, it has been shown that the capacitation 
dependent tyrosine phosphorylation is triggered by an increase of cyclic AMP.  The best 
characterized effector of cAMP in sperm is PKA.  This have been demonstrated using 
specific inhibitors of PKA which block the increase in tyrosine phosphorylation (Visconti 
et al. 1995) and more recently using a genetic-chemical switch approach to study the 
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temporal regulation of PKA (Morgan et al. 2008).  The kinase(s) that mediate this 
signaling pathway, phosphorylating tyrosine residues downstream of the serine/threonine 
kinase PKA, still remain obscure.   
Tyrosine kinases mediate very diverse signaling pathways including growth, 
differentiation, metabolism, adhesion, motility, death.  They can be divided in two 
classes: receptor and non receptor (or cytoplasmic).  Cytoplasmic tyrosine kinases are 
subdivided into 10 families. The Src family of tyrosine kinases has been implied as 
modulator of events associated with sperm capacitation by work from several laboratories 
(Baker et al. 2006; Lalancette et al. 2006b; Lalancette et al. 2006a; Lawson et al. 2008; 
Mitchell et al. 2008; Varano et al. 2008). 
Of viral nature, Src was discovered as the agent causative of fibro sarcoma in 
chicken by Peyton Rous in 1911.  The cellular analog, c-Src was the first proto-oncogenic 
tyrosine kinase discovered by J.  Michael Bishop and Harold E. Varmus (Bishop et al. 
1978).  Src family members share the same three domains, an N-terminal SH3 domain, a 
central SH2 domain and a tyrosine kinase domain, SH1. c-Src is phosphorylated in a 
tyrosine residue on the c-terminus, rendering the kinase inactive. This changes the 
conformation of the protein producing a binding site for the SH2 domain which, when 
bound, facilitates binding of the SH3 domain the linker between the SH2 and SH1 
domains. This SH3 binding, misaligns the residues of the kinase domain, causing 
inactivation of the enzyme (Ingley 2008). 
The Src family in mammals is constituted by Src, Hck, Lck, Fyn, Lyn, Lck, Blk, 
Fgr and Yes (Ingley 2008).  Src, Fyn and Yes are ubiquitous. They can vary in the level 
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of expression or a spliced variant can be expressed in a cell specific manner. Blk, Fgr, 
Hck. Lck and Lyn are primarily found in hematopoietic cells (Thomas and Brugge 1997).   
It has been reported in human sperm capacitation c-yes (Leclerc and Goupil 2002) 
and Src (Lawson et al. 2008) are modulated by calcium.  This group has also reported the 
presence of hck in bovine sperm (Lalancette et al. 2006b; Lalancette et al. 2006a; 
Bordeleau and Leclerc 2008).  Varano et al (2008) reported that in humans Src protein 
trigger the acrosome reaction and the capacitation.    Recently, Baker et al (2006) 
proposed Src as a downstream effector of PKA.  According to their model, PKA directly 
phosphorylates Src in serine 17 residue, activating the tyrosine kinase activity.  They also 
suggest that PKA phosphorylates Csk, a known inhibitor of Src kinase activity.  This 
PKA phosphorylation of Csk would indirectly cause the activation of Src. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Materials 
The following antibodies were used: anti-phosphotyrosine antibody (clone 4G10; 
Upstate Biotechnology, Lake Placid, NY); anti-rabbit muscle aldolase (CHEMICON 
International); anti-pyruvate dehydrogenase E1 α-subunit (mouse IgG1, monoclonal 
9H9); anti-pyruvate dehydrogenase E1β-subunit (mouse IgG1, monoclonal 17A5; 
Molecular Probes, Eugene, OR); anti-VDAC (PA1-954 rabbit polyclonal; Affinity Bio 
Reagents, Golden, CO); anti-Src (36D10; Cell Signaling Technology Inc, Danvers, MA); 
anti-Src (GD11; Upstate biotechnology, Lake Placid, NY); anti-β tubulin  monoclonal 
antibody  (Clone E7) developed by Chu and Klymkowsky (9) were obtained from the 
Developmental Studies Hybridoma Bank developed under the auspices of the National 
Institutes of Health, NICHD, and maintained by The University of Iowa Department of 
Biological Sciences, Iowa City, IA.; anti-fyn, anti-yes and anti- hck (BD Biosciences); 
anti-lck,(3A5), anti-lyn (H6), anti-blk (C-20) and anti-Fgr (D6) from Santa Cruz 
Biotechnology, Inc.; anti-phospho-PKA substrate (100G7) was purchased from Cell 
Signaling Technology Inc., (Danvers, MA).  Horseradish peroxidase-conjugated anti-
mouse IgG (Jackson Immunoresearch Laboratories, West Grove, PA); horseradish 
peroxidase-linked anti-rabbit IgG (GE Healthcare) and horseradish peroxidase-linked 
anti-goat antibody (Sigma-Aldrich, Saint Louis, MO). ECL and ECL plus 
chemiluminescence detection kits were from Amersham Biosciences (Uppsala, Sweden). 
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Protein G Sepharose was from GE Healthcare.  PVDF membrane was from Millipore 
(Bedford, MA). Alexa 555-conjugated anti-rabbit antibody, Alexa 555-conjugated anti-
mouse antibody, Texas Red-conjugated anti-goat antibody, Mitotracker Green and Alexa 
488-labeled PNA were from Molecular Probes (Invitrogen). SU6656 was purchased from 
Calbiochem (La Jolla, CA). SKI606 was purchased from Husker Chemical Ltd.  Cdc 2 
was purchased from Upstate biotechnology (Lake Placid, NY).  All other reagents were 
purchased from Sigma (St. Louis, MO). 
Preparation Of Mouse Sperm 
Caudal epididymal sperm were collected from CD1 retired breeder males (Charles 
River Laboratories, Wilmington, MA) sacrificed in accordance with IACUC guidelines. 
Cauda epididymis from each animal were placed in 1 ml of modified Krebs-Ringer 
medium (Whitten’s-HEPES buffered medium) (WH) (Moore et al. 1994) containing 100 
mM NaCl, 4.7 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5.5 mM glucose, 1 mM 
pyruvic acid, 4.8 mM L(+) -lactic acid hemicalcium salt in 20 mM HEPES, pH 7.3. This 
medium, prepared in the absence of bovine serum albumin (BSA) and NaHCO3, does not 
support capacitation. Sperm released into the media during a 10 min time period were 
counted and collected by centrifugation at 800 x g for 10 min at room temperature. Sperm 
pellets were resuspended in WH medium (without BSA or NaHCO3) and then 1-2 x 106 
sperm were incubated in 1 ml of the medium at 37°C for the indicated time periods. 
When the sperm were incubated under capacitating conditions, WH medium was 
supplemented with 5 mg/ml BSA plus 20 mM NaHCO3. In all cases, pH was maintained 
at 7.3. In some experiments, capacitating medium contained 2-hydroxypropyl-β-
cyclodextrin (2-OH-propyl-β-CD)(3mM) instead of BSA (Visconti et al. 1999), plus 20 
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mM NaHCO3, dbcAMP (1mM) and IBMX (100uM). To test the effect of SU6656 and 
SKI606 in capacitation, sperm were pre incubated with them for 30 min previous to the 
start of the capacitation. Sperm motility was checked in all the experiments and the 
percentage of motile sperm was over 80%. 
Sds-Page And Western Blots 
Phosphorylated proteins were analyzed in protein extracts from mouse sperm. 
Sperm pellets were washed in 1 ml of PBS, resuspended in Laemmli sample buffer 
(Laemmli 1970) without 2-mercaptoethanol and boiled for 5 min. After centrifugation, 
the supernatants were saved, and 2-mercaptoethanol was added to a final concentration of 
5%. Samples were boiled for 5 min and subjected to SDS-PAGE using 8-10% mini-gels; 
protein extracts equivalent to 1-2 x 106 sperm were loaded per lane. Each gel contained 
dual-prestained molecular weight standard (Bio-Rad, Hercules, CA). Proteins were 
transferred to PVDF membranes and incubated in appropriate blocking solution for 1 h at 
the room temperature. Western blots were conducted as described and developed using 
ECL chemiluminescence reagents. 
Two-Dimensional Gel-Electrophoresis 
Two dimensional gel electrophoresis (2D-PAGE) was conducted as described 
(Jha et al., 2006); briefly, after incubation in media that support or not capacitation, 
sperm were centrifuged and resuspended in a modified Celis extraction/rehydration 
buffer (5 mM urea, 2 mM thiourea, 2% CHAPS, 0.2% ampholytes pH 3-10, 50mM DTT, 
0.0002% Bromophenol blue, 1 mM sodium orthovanadate, 10 mM sodium fluoride, 30 
mM β- glyceraldehyde, 2 mM EGTA and protease inhibitors), vortexed for 2 min and 
kept on ice for 30 min. After centrifugation at 12,000 x g for 5 min, extracted proteins 
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(equivalent to 16 x 106 sperm per strip) were loaded passively onto IPG strips (pH 3-10) 
and incubated overnight at room temperature. Isoelectric focusing (IEF) was performed 
using Protean IEF Cell apparatus (BioRad, Richmond, CA) starting with 15 minutes at 
250 V and rapid increase to 4000 V overnight to a final 20,000 Vh. After IEF, IPG strips 
were equilibrated in equilibration buffer (6M urea, 2% SDS, 0.05 M Tris/HCl, 2% DTT, 
20% glycerol) at room temperature for 10 min, followed by incubation on a second 
equilibration buffer in which DTT was replaced with 2.5% iodoacetamide, for 10 min at 
room temperature. Second dimensional gel-electrophoresis was performed on 10% 
SDSPAGE gels. Proteins were transferred onto PVDF membranes and analyzed by 
Western blotting as described above or developed using silver stain as previously 
described (Ficarro et al. 2003). 
Image Analysis Of 2 D Gels 
Gel electrophoresis was performed concurrently to ensure equivalent 
electrophoretic conditions. Gels were stained with silver (Ficarro et al. 2003) or 
transferred to PVDF membrane and probed with α PY (clone 4G10, UBI). The silver 
stained gel and X-ray films (short and long exposure of ECL’s) were scanned at 300 dpi 
using a desktop HP scanner. Digitized images were overlaid in Adobe Photoshop 7.0 
using different % of transparency. Using known “landmarks”, such as hexokinase and 
tubulins, the silver-image was aligned with the ECL-images. After marking all reactive 
spots on the ECL-image with arrows, the ECL image was hidden and the arrows 
identified corresponding silver stained spots.  These spots were then cored from the silver 
stained gel and submitted for mass spectrometry analysis, performed at the Proteomic 
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Mass Spectrometry Facility, University of Massachusetts Medical School, Worcester, 
MA, USA. 
 
Multi Tissue Western Blot 
 Tissues from CD1 male retired breeders, or from females, were collected and 
proteins were extracted using RIPA buffer (10 mM Tris pH 7.2, 150 mM NaCl, 0.1 % 
SDS, 1% Triton X-100, 1 % deoxycholate, 5 mM EDTA, protease and phosphatase 
inhibitors). Tissues were resuspended in the buffer, set on ice for 30 minutes and spun 
down for 20 minutes. Protein concentration was assayed using the BCA (bicinchoninic 
acid) kit from Pierce, using bovine serum albumin (BSA) as standards. The absorbance 
was measured at 562 nm using a DYNEX plate reader and DYNEX Revelation software 
4.02 (DYNEX Technologies, Worthing, UK). In each lane 10 µg of total protein was 
loaded in an SDS-PAGE 10 % gel. Proteins were transferred onto PVDF membranes and 
Western blotting was performed using anti-aldolase antibody. 
Indirect Immunofluorescence Localization 
Sperm obtained by the swim-up method in WH medium (without BSA or 
NaHCO3), were washed once, resuspended in PBS at a concentration of 1-2 x 105 
sperm/ml and seeded on 8-well glass slides. After air-dried, sperm were fixed with 3.7% 
paraformaldehyde in PBS for 15 min at room temperature, washed with PBS (4 washes 
each for 5 min) and permeabilized with 0.5% Triton X-100 for 5 min. Following 
permeabilization, sperm were treated with 10% BSA in PBS for 1 h at room temperature, 
and then incubated either with the respective primary antibody (1:50-1:250) diluted in 
PBS containing 1% BSA, or with the same concentration of the 
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corresponding normal purified IgG; incubations were carried out at 4°C overnight. After 
incubation, sperm were washed thoroughly with PBS and incubated with the 
corresponding Alexa 555-conjugated secondary antibody (1:200) diluted in PBS 
containing 1% BSA for 1 h at room temperature; these solutions also contained Alexa 
488-conjugated PNA (1:100) for staining acrosomes, and Mitotracker (1:1000) for 
detecting mitochondria. Incubation with the secondary antibody was followed by 4 
washes in PBS, mounting using Slow-Fade Light reagents (Molecular Probes, Eugene, 
OR) and observation by epifluorescence microscopy using a Zeiss Axiophot microscope 
(magnification 60x) (Carl Zeiss, Inc. Thornwood, NY). DIC images were taken in 
parallel, and served as control for sperm morphology. Negative controls using secondary 
antibody alone were also used to check for antibody specificity (not shown). 
Triton X-100 Extraction 
For the separation of the Triton soluble and Triton insoluble (assumed to be the 
cytoskeletal) fractions, after incubation in media supportive or not of capacitation, mouse 
sperm samples were pelleted and resuspended in a Triton extraction buffer (1 % Triton 
X-100, 1 mM EGTA, 5 mM EDTA, protease and phosphatase inhibitors in PBS) and 
kept on ice for 30 min. After the incubation samples were spun at 10,000g for 2 min and 
supernatant (soluble fraction) was kept on ice. The remaining pellet (non soluble fraction) 
was resuspended in Triton extraction buffer and vortexed briefly. Sample buffer was 
added and samples were boiled for 5 min. After centrifugation, the supernatants were 
saved, and 2-mercaptoethanol was added to a final concentration of 5%. Samples were 
boiled for 5 min and subjected to SDS-PAGE using 10% mini-gels as described in the 
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SDS-PAGE and Western blot methodology and developed with the antibodies indicated 
in the respective figure. Each lane contains equivalent sperm amounts (~ 2 x 106 cells). 
Aldolase Activity 
The catalytic activity of aldolase towards the substrate fructose-1,6- biphosphate 
(FBP) was determined fluorometrically by measuring the decrease in β-NADH 
fluorescence over time in a coupled assay using α- glycerol-phosphate 
dehydrogenase/triose phosphate isomerase (αGDH/TPI) and FBP as substrates (Racker 
1947; Bergmeyer 1974).   All solutions were made up in 100 mM Tris-HCl buffer, pH 
7.4. The assay media contained the following: 30 mM FBP, 130 nM of β-NADH and 2.5 
UI of α-Glycerophosphate Dehydrogenase/Triosephosphate Isomerase Enzyme Solution 
(Sigma G-6755). To set the parameters for fluorescent acquisition, the emission spectra 
for 1 mM β-NAD (Sigma N-1511) and β- NADH (Sigma N-8129) were obtained in a 300 
to 580 nm wavelength range, exciting from 300 to 412 nm wavelengths. A Jobin Yvon 
Horiba Fluorolog-3 fluorometer, equipped with DataMax V2.2 software was utilized for 
data acquisition. From the resulting spectra the 367/460 nm wavelength 
excitation/emission pair for β-NADH was chosen. Using this combination of 
wavelengths, β-NAD has no fluorescent emission (see Fig. 6 A in Results). To determine 
the activity of sperm aldolase, cauda epididymal sperm was obtained as previously 
described and placed in either capacitating or non capacitating conditions for 1 hour. 
After incubation sperm aldolase Triton extraction was carried out. Briefly, sperm were 
sequentially centrifuged twice at 10,000 g for 30 second and supernatants were discarded. 
The pellet was resuspended in 100 mM Tris-HCl, pH 7.4, 0.5 % Triton, 1 mM sodium 
orthovanadate, 10 mM sodium fluoride, 30 mM β-glyceraldehyde, 2 mM EGTA, protease 
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inhibitors and incubated on ice for 30 minutes. This extract was considered to be total 
sperm extracts. To obtain the triton soluble and particulate fractions, the sample was spun 
at 10,000g for 2 minutes. The remaining pellet was resuspended in extraction buffer and 
vortexed briefly. All the fractions were assayed; for each measurement, data was 
transformed from count per second (cps) to velocity, expressed in nM/sec, considering 
that the maximum fluorescence was obtained at 130 nM of NADH (initial concentration) 
and the minimal fluorescence obtainable coincided with 0 nM of β-NADH. From the 
graph of concentration versus time, the initial velocity of the enzymatic reaction (V0) was 
calculated as the slope of the lineal phase of the curve, using an in-lab, custom-written 
program in Igor software (Wavemetrics, Inc. Lake Oswego, OR), and expressed as nM β-
NADH consumed per second (nM/sec). To determine kinetic parameters (Km and Vmax) 
Prism4 software (GraphPad software, Inc) was used adjusting the V0 vs. substrate 
concentration curve to the Michaelis-Menten equation: Y=Vmax X/ (Km+X), where X is 
the substrate concentration (mM) and Y is the enzyme velocity (mM/sec).   
Immunoprecipitation Src Kinase Assay 
 The activity of the Src tyrosine kinase was evaluated by immunoprecipitation of 
Src using the anti-Src antibody (4 µg/ ~ 10 x 106 cells) mouse monoclonal (clone GD11) 
and anti-tubulin (clone E7) as a negative control.  After capacitation samples were 
centrifugated at 1700 x g for 1 min.  The resulting pellet was dissolved in RIPA buffer 
(10 mM Tris-HCl pH 7.2, 50 mM NaCl, 0.1 % SDS, 1%(v/v) Triton X-100, 1 mM 
EDTA, 1 mM sodium orthovanadate and protease inhibitors), kept on ice for 30 min and 
centrifuged at 2500 x g at 4° for 5 min.  Supernatants were incubated with antibodies at 
4°C for 2 hours with constant rocking.  After the addition of protein G Sepharose beads, 
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the reactions were incubated in the same conditions for 1 hour.  The isolated Src protein 
was subjected to a kinase reaction.   
As a substrate for Src kinase the synthetic peptide cdc2 (KVEKIGEGTYGVVYK) was 
used at a final concentration of 100 µM.  The final concentration of the reaction buffer 
was 25 mM HEPES, 1% (v/v) Triton X-100, 0.5 mM DTT, 1 mg/ml BSA, 0.5 mM 
EGTA, 40 µM ATP, 1 µCi 32P, 10 µM aprotinin, 10 µM leupeptin, 100 µM sodium 
orthovanadate, 5 mM p-Nitrophenyl Phosphate (PNPP) and 40 mM β-glycerophosphate, 
10 mM MnCl2. Reactions were then incubated for 15 min at 30 °C.   The reactions were 
stopped by adding 20 ml 20% TCA, cooled on ice for 20 by min, and centrifuged at room 
temperature for 3 min at 10,000g. Thirty microliters of the resultant supernatant was then 
spotted onto phosphocellulose papers (2 x 2 cm) (Whatman P81). The phosphocellulose 
papers were washed 5 x 5 min in 5 mM phosphoric acid with agitation, dried, placed in 
vials with 2.5 ml of scintillation fluid (ICN; EcoLite), and subjected to liquid scintillation 
counting. The experiment was repeated at least three times and was performed in 
triplicate; the means ± SE are shown from a representative experiment.  
In Vitro Pka Activity Assay 
 PKA activity assay was performed as previously described (Visconti et al. 1997); 
briefly, sperm cells (~105) were incubated in the presence of 1 mM db-cAMP, 100 µM 
IBMX, 1 % Triton (v/v) in kinase buffer containing 40 µM ATP, 1 µCi 32P ATP, 10 mM 
MgCl, 100 µM Kemptide and inhibitors as specified, over a period of 30 min at 30 °C.  
The reactions were stopped and processed as described for the immunoprecipitation Src 
kinase assay.  
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CHAPTER III 
IDENTIFICATION OF PROTEINS UNDERGOING TYROSINE 
PHOSPHORYLATION UPON MOUSE SPERM CAPACITATION 
 
Introduction 
Mammalian sperm are not ready to fertilize the egg immediately after ejaculation; 
they need to undergo a series of biochemical and physiological changes in the female 
reproductive tract collectively known as capacitation (Yanagimachi 1994). Although 
capacitation was discovered in the 1950s (Austin 1951; Chang 1951), the signaling 
pathways that regulate this process are not well established. Over the years, capacitation 
has been described using sperm functional assays and a series of endpoints have been 
considered to be part of this process. Among them, the ability of the sperm to fertilize the 
egg is the initial definition of capacitation and still the most important evidence that 
sperm are capacitated. More recently several authors have used two other functional 
correlates of capacitation. First, it is considered that only capacitated sperm can undergo 
an agonist-induced acrosome reaction (AR). Second, because sperm hyperactivation is 
necessary for fertilization, this change in motility pattern is also considered part of the 
capacitation process. Therefore, when one attempts to understand capacitation at the 
molecular level, it is necessary to consider events occurring both in the head (i.e., 
preparation for the AR) and in the tail (i.e., motility changes).  
During the last ten years, at the molecular level, work from different laboratories 
in several mammalian species has demonstrated that capacitation is correlated with a 
cAMP-dependent increase in tyrosine phosphorylation (Visconti et al. 1995; Leclerc et al. 
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1996; Galantino-Homer et al. 1997; Kulanand and Shivaji 2001). Most of these studies 
are focused on determining how these posttranslational changes are regulated by different 
compounds in the capacitation medium known to be essential for capacitation(Salicioni et 
al. 2007). However, little is known about the role of the proteins that undergo the 
capacitation-associated increase in tyrosine phosphorylation. Recent work in humans, 
hamster and boar has started to identify some of the proteins that serve as substrates for 
tyrosine phosphorylation. The use of 2-dimensional (2D) gel electrophoresis followed by 
tandem mass spectrometry (MS/MS) provides a comprehensive approach to the analysis 
of proteins involved in cell signaling (Blomberg 1997). Specifically, changes in tyrosine 
phosphorylation can be monitored using 2D gel electrophoresis followed by Western blot 
analysis with anti- phosphotyrosine (α PY) antibodies (Naaby-Hansen et al. 1997; Ficarro 
et al. 2003). Proteins that undergo changes in tyrosine phosphorylation during cellular 
processes can be then isolated from a complementary gel and sequenced by MS/MS. In 
the present study, we have used this approach to identify sperm proteins that undergo 
tyrosine phosphorylation during mouse sperm capacitation. Our findings are consistent 
with the ones obtained for human sperm (Ficarro et al. 2003). Similar to that analysis, we 
have found that in mouse sperm, tubulin, VDAC, PDH E1 β chain, glutathione S-
transferase, NADH dehydrogenase (ubiquinone) Fe-S protein 6, acrosin binding protein 
precursor, proteasome subunit alpha type 6b, and cytochrome b-c1 complex are 
phosphorylated in tyrosine residues. Interestingly, among the proteins phosphorylated on 
tyrosine residues we have identified two recently described testis-specific aldolases, 
(Vemuganti et al. 2007). Aldolase is the fourth enzyme of glycolysis; in mouse sperm, 
this metabolic process is the main pathway for ATP production as was demonstrated 
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using null mutants of other glycolytic enzymes (Miki et al. 2004). Because capacitation is 
correlated with hyperactivation, we hypothesize that tyrosine phosphorylation of aldolase 
during sperm capacitation could be involved in the regulation of the glycolytic pathway 
during this process. In addition to the localization of aldolase in the sperm principal 
piece, similar to hexokinase, aldolase was also found in the sperm anterior head 
suggesting that glycolysis could have additional functions during the preparation of the 
sperm for the acrosome reaction.   
Results 
 
Characterization of proteins that undergo tyrosine phosphorylation during 
capacitation 
To identify those proteins that undergo tyrosine phosphorylation upon 
capacitation, mouse sperm were incubated for 90 min. under conditions that support (+ 
βCD, + NaHCO3) or not (-βCD,- NaHCO3) capacitation. Aliquots of each treatment 
were extracted in sample buffer and analyzed by Western blot using α PY antibodies 
(Fig. 4A). As expected, in conditions that support capacitation, an increase in protein 
tyrosine phosphorylation was observed. Samples from each treatment were extracted with 
Celis buffer and separated using 2D PAGE. For each experimental condition (NCap and 
Cap), 2 gels were run in parallel; one series of gels were silver stained with while the 
other was transferred and probed with α PY. Analysis for capacitated sperm is shown in 
Fig. 4 B, D; NCap samples probed in parallel using α PY served as controls (Fig. 4 C. 
Both the silver stained gel and the Western blot were scanned and compared. Several 
protein spots showing α PY staining were excised, digested, sequenced by MS/ MS 
(Table I) and the predicted localization of each spot is shown in Fig.4B,D. Among the 
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mouse proteins identified in this search, VDAC, glutathione S-transferase, proacrosin 
binding protein (sp32), pyruvate dehydrogenase (E1 beta subunit), 
 
 
 
 
 
 
 
 
Fig.4. Analysis of the capacitation-associated increase in protein tyrosine 
phosphorylation by 2-D gels.  Mouse sperm were incubated for 90 min in media that 
do not support (minus 2-OH-p-βCD, minus HCO3 -) or support capacitation (plus 2-
OH-p-βCD, plus HCO3 - ). After this incubation period, aliquots from each condition 
were extracted either with SDS sample buffer for monodimensional α-pY Western 
blot (A) or with Celis buffer for 2D PAGE analysis (B,C,D) . 2D gels were then 
developed by α-pY Western blots (A,C,D) or with silver stain (B) . 2D images from 
capacitated sperm were overlaid using AdobePhotoshop and the silver stained 
proteins that exhibited tyrosine phosphorylation (shown by black arrows panel (D) 
were cored (shown by white arrows in panel (B) and sequenced by MS/MS. The 
following proteins were identified: 1,2, Alodart1, Aldoart2; 3, glutathione S-
transferase; 4, NADH dehydrogenase (Ubiquinone); 5, acrosin binding protein 
(sp32); 6, proteasome subunit alpha type 6b; 7, PDHβ; 8, tubulin β; 9, cytochrome b-
c1 complex subunit 1; 10, VDAC, numbered in the same order as in Table I. 
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tubulin, NADH dehydrogenase (ubiquinone) and the proteasome subunit alpha type 6 
were previously detected as substrates for tyrosine phosphorylation in human sperm 
undergoing capacitation (Ficarro et al., 2003). Interestingly, two of the proteins that have 
not been yet described as tyrosine phosphorylated substrates were testis specific isoforms 
of the aldolase family recently cloned (Vemuganti et al., 2007).   
To confirm these findings and analyze the localization of some of the identified 
proteins, three of the sequenced proteins including the aldolase isoforms were further 
analyzed using commercial antibodies. Antibodies against aldolase from rabbit muscle, 
anti-pyruvate dehydrogenase E1 β (PDHβ) chain and anti-voltage dependent anion 
channel (VDAC) were used to probe Western blots of total mouse sperm extracts (Fig. 5).  
 
Each of these antibodies recognized proteins at the appropriate molecular weight. 
As expected from our two-dimensional sequencing as well as from the recently published 
work from Vemuganti et al. (Vemuganti et al., 2007), anti-aldolase antibodies recognized  
Fig. 5. Validation of anti-aldolase, anti-PDHE1β and anti-VDAC antibodies 
using mouse sperm extracts. Total mouse sperm extracts (~ 2 x 106 cells) were 
lysed in sample buffer and separated by 10 % SDS-PAGE and transferred to 
Inmobilon P. Western blots were performed using anti-aldolase, anti-pyruvate 
dehydrogenase E1β chain and anti-VDAC antibodies. Experiments shown are 
representative of experiments performed at least three times with similar results. 
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the shorter (~ 40 kDa) and longer (~ 50 kDa) sperm aldolase isoforms. Similarly, the anti-
VDAC antibody recognized two proteins of similar molecular weights, implying that 
more than one VDAC is present in sperm as suggested previously (Hinsch et al., 2001; 
Hinsch et al., 2004); these molecular weights corresponded to the excised spots from the 
2D gels. 
Fig. 6. Antibodies against aldolase, pyruvate dehydrogenase E1β chain and 
VDAC matched the tyrosine phosphorylated spots in capacitated mouse 
sperm. Mouse sperm were incubated in capacitation-supporting medium for 90 
minutes. After this incubation period, proteins were extracted in Celis buffer and 
separated by 2 D PAGE. Parallel immunoblots were probed using α PY antibodies 
(A), anti-aldolase (B), anti- pyruvate dehydrogenase E1β chain (C), and anti-
VDAC (D) antibodies. Arrows with different shapes indicate the tyrosine 
phosphorylated spots in (A) and the respective proteins in the other Western blots. 
Results from a representative experiment are shown. 
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 To further confirm this finding, aliquots of capacitated sperm protein extracts 
were analyzed by 2D PAGE Western blots using anti- PY, anti-aldolase, anti-PDHβ and 
anti-VDAC antibodies. These Western blots show that in addition to the different 
molecular weight, both aldolase isoforms are separated as a trail of proteins depicting a 
series of isoelectric points. Similarly, PDHβ and the two VDAC spots were confirmed 
(Fig. 6 C, D). These Western blots show that, in addition to the different molecular 
weight, both aldolase isoforms are separated as a trail of proteins depicting a series of 
isoelectric points. In each case, the arrows indicate the sequenced spots as shown in Fig. 
6B. Similarly, PDHβ and the two VDAC spots were confirmed (Fig. 6C, D).  
The localization of these proteins was analyzed by immunofluorescence. As 
expected, VDAC and PDHβ were found to be present in the midpiece where the 
mitochondria reside, while aldolase was found in the principal piece, the sperm cell 
compartment in which glycolysis has been reported. However, these three tyrosine 
phosphorylation substrates also localized to unexpected regions in the sperm. For 
example, both aldolase and VDAC were also found in the anterior head; this localization 
is atypical for these proteins and could be related with specific functions in the acrosomal 
compartments. Interestingly, both proteins are lost from the head after the acrosome 
reaction (Fig. 7 and data not shown). 
 
To further analyze the sperm distribution of these proteins, the sperm were 
extracted in the presence of 1% Triton X-100 for 30 min at 4ºC and the solubility of 
aldolase, PDHβ and VDAC analyzed by Western blot. Interestingly, these three proteins 
distribute in both Triton X-100 soluble and insoluble fractions, and their distribution does 
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not appear to change during capacitation (Fig. 8A). In addition, anti-aldolase antibodies 
were used to test whether the high molecular weight aldolase isoform is also found in 
other tissues. Multi-tissue Western blots indicate that the high MW aldolase is only found 
in sperm and testis extracts (Fig. 8B), confirming previous observations (Vemuganti et 
al., 2007). 
 
Fig. 7. Immunolocalization of phosphorylated protein targets in mouse sperm. 
Mouse sperm were air-dried, fixed, permeabilized and probed with antibodies for 
anti-aldolase (A) , anti-pyruvate dehydrogenase E1β chain (B) and anti-VDAC (C) . 
PNA (peanut agglutinin) stains the acrosome and mito-tracker is used as a 
mitochondrial marker (D-F). DIC images are shown in (G-I). As negative controls, 
normal IgG from goat (aldolase), mouse (dehydrogenase E1β chain) and rabbit 
(VDAC) were run in parallel. Images shown are representative of at least three 
repetitions with similar results. 
 26 
 
 
 
 
 
 
 
 
 
 
Aldolase activity does not change during capacitation 
Although the capacitation-associated increase in protein tyrosine phosphorylation 
was described more than 10 years ago, still it is not clear how these posttranslational 
changes affect sperm function. Because glycolysis is the main source of energy in mouse 
sperm, the finding that aldolase is tyrosine phosphorylated during capacitation opens the 
Fig. 8. Solubility of tyrosine phosphorylation targets in Triton X 100 and Western 
blot analysis of mouse tissues using α-aldolase antibodies. (A) Cauda mouse sperm 
were incubated in conditions that support (Cap) or not (Non) capacitation for 90 min. 
After this incubation the sperm were centrifuged and resuspended in buffer containing 
1 % Triton X 100. After 30 min. the sperm were centrifuged and the pellet (Pt) and 
supernatant (Sn) analyzed by Western blots using anti-aldolase, anti- PDHβ and anti-
VDAC antibodies as described. The experiment shown is representative of three 
similar ones. (B) Immunoblot showing the presence of higher molecular weight 
aldolase in sperm and testis protein extracts. Ten micrograms of RIPA extracted 
tissues of CD1 male or female mouse were separated in 10 % SDS-PAGE and 
immunoblotted with anti-aldolase antibody. A representative experiment of three 
repetitions is shown. Abbreviations: Sp(sperm); T (testis); M (muscle); H (heart); O 
(ovary); Li (liver); K (kidney); Lu (lung); Hy (hypothalamus); Cx (cortex); Ce 
(cerebellum); P (pituitary). 
 
 27 
possibility that tyrosine phosphorylation is involved in the regulation of aldolase activity 
and glycolysis during this process. To analyze whether this was the case, total sperm 
aldolase activity was measured, as well as the activity associated to soluble and 
particulate sperm compartments. To measure aldolase activity, a modified indirect 
spectrofluorometric method was used taking into consideration the different emission of 
NADH and NAD when excited at 367 nm (Fig. 9A). At low concentrations of NADH, 
the fluorescence using 367/460 nm excitation/emission pair was linear (Fig. 9B). Because 
aldolase activity is coupled to the transformation of NADH to NAD when α-glycero-
phosphate dehydrogenase, triose phosphate isomerase (αGDH/TPI) and FBP are present, 
the decrease in NADH was used to measure aldolase activity. Total sperm aldolase 
activity was linear in the conditions used in this assay (Fig. 9C); when the cytosolic and 
particulate fractions were assayed, similar linearity was found (data not shown). As 
explained in methods, the kinetics were evaluated in real time and the activity was 
calculated from the slope of NADH consumption (Fig. 9D). As shown (Fig. 9 E,F), both 
kinetic parameters (Km and Vmax) indicative of aldolase activity in sperm incubated in 
media that support (Cap) or not (NCap) capacitation did not change. Similar results were 
obtained when the particulate and the cytosolic fractions were assayed independently 
(data not shown). 
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Fig. 9. Aldolase activity does not change during capacitation. (A) Emission spectrum 
of NADH and NAD. The spectra for 1mM β-NADH and 1 mM β-NAD were obtained 
with an excitation wavelength of 367nm. The emission peak was observed at 460 nm; 
using these parameters NAD had very low fluorescent emission. (B) Fluorescence is linear 
with NADH when low concentrations are used. NADH was dissolved in Tris/HCl buffer 
at different concentrations and the fluorescence was determined as described using a 
367/460 nm excitation/ emission pair. A NADH concentration of 130 µM was used in the 
aldolase enzymatic assays. (C) Aldolase activity is linear with the sperm concentration. 
Sperm were resuspended in Triton buffer and serial dilutions were made and assayed for 
aldolase activity as described. (D) NADH consumption vs. time after addition of sperm as 
a source of aldolase. The substrates for the coupled enzymatic reactions: Fructose 1,6-Di 
phosphate, G 3-P,á-GDH, TPI and NADH in Tris- HCl buffer were placed in the same 
cuvette and continuous NADH fluorescence was registered before and after addition of 
sperm pellets. The slope of each curve was used to determine the Vo. (E) Aldolase activity 
in non capacitated and capacitated sperm as a function of substrate (Fructose 1,6-
biphosphate) concentration. Sperm were incubated in either non capacitating or 
capacitating conditions and aldolase activity was assayed at different Fructose 1,6-
biphosphate concentrations. Each measurement was repeated three times in three different 
experiments, the values represent the mean ± SEM. (F) Kinetic parameters for aldolase 
from non capacitated and capacitated sperm. The curves of Vo vs. substrate concentration 
shown in (E) were adjusted to the Michaelis-Menten equation: Y=Vmax*X/(Km+X), 
where X is the substrate concentration (mM) and Y is the enzyme velocity (mM/sec). 
 
 29 
 
Discussion 
Protein phosphorylation plays a role in the regulation of intracellular processes such as 
transduction of extracellular signals, intracellular transport, and cell cycle progression. In 
sperm, capacitation is associated with a phosphorylation cascade which involves a PKA-
regulated increase in protein tyrosine phosphorylation (for review see Salicioni et al., 
2007)). Although the correlation between sperm capacitation and the increase in tyrosine 
phosphorylation has been reproduced in several mammalian species (Visconti et al., 
1995a; Visconti et al., 1995b; Leclerc et al., 1996; Galantino-Homer et al., 1997; Kalab 
et al., 1998), the identity and functions of kinases and their targets in sperm are not well 
defined. An initial approach to investigate the role of phosphorylation in capacitation is to 
identify proteins phosphorylated during this process and to characterize the kinases 
involved in their phosphorylation. In this respect, the use of 2D PAGE followed by 
MS/MS provides a comprehensive approach to the analysis of proteins involved in cell 
signaling (Blomberg, 1997; Alms et al., 1999; Soskic et al., 1999; Lewis et al., 2000). 
Specifically, changes in tyrosine phosphorylation can be monitored using 2-D gel 
electrophoresis (O’Farrell, 1975, Gorg et al., 1988) followed by Western blot analysis 
with α-PY antibodies. Proteins that undergo changes in tyrosine phosphorylation during 
capacitation can then be isolated from a duplicated gel stained with silver and sequenced 
by MS/MS. This strategy has been used before for the identification of tyrosine 
phosphorylated proteins in sperm from human (Naaby-Hansen et al., 1997; Ficarro et al., 
2003), hamster (Kumar et al., 2006) and boar sperm (Bailey et al., 2005). In this work, a 
similar approach was used to start the characterization of tyrosine phosphorylated 
substrates in mouse sperm. Capacitation prepares the sperm to undergo the acrosome 
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reaction and also is associated with changes in sperm motility (e.g. hyperactivation) in a 
number of species (Visconti and Kopf, 1998). Therefore, it can be hypothesized that 
components of the sperm exocytotic and motility machinery could be found among the 
proteins that undergo tyrosine phosphorylation during capacitation. In particular, motility 
changes require elevated levels of ATP to support coordinated movements of the 
flagellum. The sources of ATP in the sperm are known to be compartmentalized; while 
oxidative phosphorylation occurs in the mid piece of the flagellum where the 
mitochondria are confined, glycolysis appears to be restricted to the principal piece. 
Although oxidative phosphorylation is more efficient than glycolysis for ATP production, 
recent work by Miki et al. (Miki et al., 2004) demonstrated that the absence of the sperm-
specific glyceraldehyde 3-phosphate dehydrogenase -S (GAPDS) in GAPDS null mice 
results in a decrease of the ATP levels to almost negligible levels in their sperm. These 
findings suggest that at least in the mouse, the main source of ATP is through the 
glycolytic pathway. Because of this relevant role of glycolysis, the identification of two 
testis-specific members of the aldolase family as tyrosine phosphorylated substrates is 
noteworthy. Fructose-1,6- biphosphate aldolase (commonly referred to as aldolase) 
catalyzes the fourth step of the glycolysis. The mechanism involves a retro-aldol 
condensation reaction that cleaves the 6 carbon biphosphorylated fructose into two 3-
carbon products: D-Glyceraldehyde 3- phosphate and dihydroxyacetone phosphate. 
Glycolysis has been highly conserved throughout evolution; however, in sperm, many 
critical glycolytic enzymes present testis-specific isoforms. These isoforms are either 
differentially spliced variants of somatic enzymes or they derived from independent 
genes. Fructose-1, 6-biphosphate aldolase is an interesting example, this gene family 
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contains three somatic members (AldoA, AldoB and AldoC), two testis-specific intronless 
genes likely evolved by retrotransposition (Aldoart1 in chromosome 4 and Aldoart2 in 
chromosome 12) (Vemuganti et al., 2007) and two testis-specific splicing variants of 
AldoA derived from the use of an extra exon in the amino-terminus region of the 
transcript (AldoA_v1 and AldoA_v2) (Vemuganti et al., 2007). In our study, sequencing 
of two tyrosine phosphorylated spots revealed peptides matching aldoart1 and aldoart2. 
Moreover, results from 2D analysis suggest that all aldolase members in sperm are 
tyrosine phosphorylated. This result suggests that aldolase and therefore glycolysis might 
be regulated by tyrosine phosphorylation in sperm. To test this hypothesis, mouse sperm 
were incubated in conditions that either support or not capacitation, and aldolase activity 
was assayed in total extracts as well as in detergent soluble and particulate fractions. In 
all conditions, the kinetics parameters (Km and Vmax) of aldolase were invariant. The 
lack of change in aldolase activity suggests that tyrosine phosphorylation does not play a 
direct role in activation of this enzyme. However, at present we cannot discard that the 
efficiency of the aldolase access to its substrates in vivo is not modified. Interestingly, 
four tyrosine phosphorylation sites have been found in somatic aldolases 
(www.phosphosite.org); three of these sites are conserved in the mouse aldoart1 and four 
of these sites are present in aldoart2. At present, the role of these phosphorylations is not 
known. The source of energy for the acrosome reaction as well as other molecular 
processes occurring in the sperm head is not clear. The ATP needed could be produced in 
the mitochondria by oxidative phosphorylation and transported to the head; or 
alternatively, the head could have the enzymes required for glycolytic ATP production. In 
addition to the expected localization of aldolase in the principal piece (Krisfalusi et al., 
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2006; Vemuganti et al., 2007), anti-aldolase antibodies also stained the acrosomal region 
of mouse sperm suggesting the presence of at least one of the aldolase isoforms in this 
region. This is consistent with the finding of another glycolytic enzyme, hexokinase type 
I, in the sperm head (Visconti et al., 1996; Travis et al., 1998). Although more research is 
needed, localization of glycolytic enzymes in the sperm head opens the possibility that in 
addition to the established role in the principal piece, glycolysis could play a role in the 
sperm head. In addition to the two testis-specific aldolases, eight other proteins were 
identified as tyrosine phosphorylation targets; from these ones, PDHβ, VDAC2, 
glutathione S-transferase were also mapped as capacitation-associated tyrosine 
phosphorylation targets  in human sperm (Ficarro et al., 2003), PDHE1α chain in hamster 
sperm (Kumar et al., 2006) and the acrosin binding protein sp32 in boar sperm (Bailey et 
al., 2005). In the case of VDAC and PDHE1β chain, commercial antibodies were used to 
confirm tyrosine phosphorylation in the assigned proteins and to analyze their 
localization in sperm by immunofluorescence. In somatic cells, the voltage dependent 
anion channels (VDACs) were first identified in the mitochondrial outer membrane; 
however, VDACs have also been localized to the plasma membrane in several cell types 
(De Pinto et al., 2003; Wang et al., 2007). In the mitochondria, VDAC is known to 
function as the gate for metabolite transport from the cytosol; although it displays a rather 
nonspecific single channel activity, usually anionic species as phosphate, chloride, 
organic anions, and adenine nucleotides are transported into the mitochondria through 
VDAC. Recent work by Hinsch et al. (Hinsch et al., 2001; Hinsch et al., 2004) 
demonstrated that VDAC2 and VDAC3 are present in bovine sperm; in particular 
VDAC2 was shown to localize to the anterior head. Although the anti-VDAC antibodies 
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used in the present investigation were not able to distinguish between the three VDAC 
isoforms, our results also indicate that in addition to the mitochondrial localization, 
VDAC is also localized to the acrosomal region in mouse sperm. At present, we can only 
speculate that tyrosine phosphorylation of VDACs may either affect the activity of these 
channels or their interaction with other sperm proteins. Mammalian PDH is a tetramer 
consisting of two alpha and two beta subunits. Contrary to the PDHα that is encoded by 
two genes, one somatic (PDHA1) and one testis-specific (PDHA2), PDHβ, encoded by 
PDHB is common to both somatic and testicular cells (Korotchkina et al., 2006). Similar 
to previous findings in human sperm (Ficarro et al., 2003), PDH1beta is tyrosine 
phosphorylated during mouse sperm capacitation. Immunofluorescence localization of 
this enzyme shows the expected mid piece staining consistent with mitochondrial 
localization; however, this enzyme was also found in the principal piece and in the 
acrosomal region. These results are consistent with the finding of Fujinoki et al. (Fujinoki 
et al., 2004) which identified PDH E1 β as part of the fibrous sheath in hamster sperm. 
Also in hamster sperm, functional studies revealed tyrosine phosphorylation of the testis 
specific PDHα subunit of this enzymatic complex. The role of the tyrosine 
phosphorylation in this case appears to be coupled to an increase in the PDH activity 
(Kumar et al., 2006). In summary, although work emanating from multiple laboratories is 
leading to a better understanding of capacitation, most of the proteins involved in this 
process remain to be characterized. In addition, it is important to highlight that although 
the increase in tyrosine phosphorylation has been correlated to sperm capacitation; it is 
still unclear how the changes in tyrosine phosphorylation are coupled to physiological 
events that occur during capacitation. The molecular identification of tyrosine kinases, 
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phosphotyrosine phosphatases, tyrosine phosphorylation substrates, and Ca2+ channels 
present in mammalian sperm will certainly expand our understanding of the molecular 
basis of capacitation. 
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CHAPTER IV 
SRC FAMILY INVOLVEMENT IN MOUSE SPERM CAPACITATION 
 
Introduction 
 
Almost 60 years ago, Austin (Austin 1952) and Chang (Chang 1951) described 
independently the requirement of the sperm in the female tract to be able to fertilize.  
Correlating to the capacitated state,  the  increase of  tyrosine phosphorylation of a subset 
of proteins has been reported in many mammalian species (Visconti et al. 1995a; Leclerc 
et al. 1996; Galantino-Homer et al. 1997; Kulanand and Shivaji 2001).   Likewise, the 
dependency of an increase of cAMP for the activation of a tyrosine kinase and 
capacitation is supported by a bevy of literature (Visconti et al. 1995b; Leclerc et al. 
1996; Galantino-Homer et al. 1997; Aitken et al. 1998; Harrison and Miller 2000).   The 
best characterized effector of cAMP in sperm cells is PKA.  The identity of tyrosine 
kinase(s) that mediates the signaling, however, is still elusive. 
 Since the tyrosine phosphorylated proteins are present in the soluble fraction, we 
aim our efforts towards cytoplasmic kinases.  Of such proteins, Src family had been 
recently proposed as mediators of the signaling pathway that leads to sperm capacitation 
(Baker et al. 2006). However, it should be kept in mind that at this point it is not possible 
to discard a role for receptor tyrosine kinases in sperm capacitation, 
Src Family Kinases 
The cytoplasmic tyrosine kinase family Src  is involved in a wide variety of 
cellular responses, including cell proliferation, migration, differentiation and survival  
(Thomas and Brugge 1997).   The first member of the family to be identified was the 
 36 
tumor causative agent, isolated by Peyton Rous in 1911, demonstrated to be of viral 
nature in 1970 (Martin 1970) and described as a kinase in 1978 (Collett and Erikson 
1978).  Its cellular counterpart, c-Src protein, was the first eukaryotic tyrosine kinase to 
be discovered (Schartl and Barnekow 1982).  The mammalian Src family is constituted 
by Src, Hck, Lck, Fyn, Lyn, Lck, Blk, Fgr and Yes (Ingley 2008).  Src, Fyn and Yes are 
expressed in most tissues. However, some are highly expressed or display alternative 
spliced variants in certain cell types.  Blk, Fgr, Hck. Lck and Lyn are  primarily found in 
hematopoietic cells (Thomas and Brugge 1997). All members have a similar 
arrangement: an N-terminal highly variable domain that bears an ancillary myristoylation 
or palmitoylation site, followed by the SH3 proline enriched and SH2 domains, and the 
enzymatic activity domain SH1.     
Interestingly, fibroblast cells have been used to show that Src is activated by PKA 
through phosphorylation on serine 17 within its amino terminus, both in vitro and in vivo 
(Stork and Schmitt, 2002). This phosphorylation of Src in serine 17 affects its 
conformation, rendering the autophosphorylation site available and triggering the 
activation of the kinase.  The promotion of sperm phosphotyrosine activity during 
capacitation arises from a crosstalk between PKA activity and TKs.  The tyrosine 
kinase(s) that is activated downstream of PKA upon capacitation still remains an open 
question.  Although not in a conclusive manner, Src tyrosine kinase have been recently 
proposed to act as a key player of the cross talk between PKA activity and tyrosine 
phosphorylation of proteins, both in human (Lawson et al. 2008; Mitchell et al. 2008; 
Varano et al. 2008) and mouse sperm capacitation . 
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A decrease in protein tyrosine phosphorylation has been observed when 
spermatozoa were incubated with Src tyrosine kinase inhibitors, such as herbimicyn A, 
erbstatin, SU6656, PP1, or PP2 (Baker 2006). These inhibitors are expected to be 
specifically directed to Src-related tyrosine kinases, suggesting the involvement of this 
family of tyrosine kinases in the capacitation-mediated increase of sperm protein 
phosphotyrosine content.   
Our objective is to elucidate the involvement of Src or Src family members in the 
tyrosine phosphorylation in mouse sperm capacitation. 
 Results 
Src kinase family tyrosine inhibitors reduce the capacitation dependent tyrosine 
phosphorylation 
 To evaluate the possible involvement of Src family of tyrosine kinases in the 
increase of tyrosine phosphorylation we used a pharmacological approach.  Mouse sperm 
were incubated in capacitation conducive conditions (+ BSA, + NaHCO3) and different 
concentrations of SU6656 and SKI606, two known specific inhibitors for Src family 
kinases (Coluccia et al. 2006).  The phosphorylation of tyrosine residues was evaluated 
by Western blot using an anti-phosphotyrosine antibody.  As seen (Fig 10) both inhibitors 
abrogated the capacitation dependent tyrosine phosphorylation in a concentration 
dependent manner. 
Presence of Src family kinases in mouse sperm 
 The inhibitors SU6656 and SKI606 are specific for not only Src kinase but all the 
members of its family. Since mammalian cells present eight known members in the Src 
kinase family (Src, Hck, Lck, Fyn, Lyn, Lck, Blk, Fgr and Yes) (Ingley 2008), we  
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decided to  determine which member(s) were possibly being affected by the inhibitor 
SU6656 and SKI606. In this regard, we assayed for the presence of the members of the 
Src kinase family in mouse sperm extracts by means of Western blots using specific 
antibodies (described in Materials and Methods) against their unique N-terminal domain 
(Fig.11).    Mouse sperm extracts were prepared using either sample buffer with 2% SDS 
or RIPA buffer.  On both samples the antibody specific for Src detected a band at the 
expected molecular weight (60kDa), similar to the positive control of mouse 
macrophages.  This antibody also recognized a lower molecular weight band, at 
approximately 50 kDa.  Alongside their respective positive controls, samples of mouse 
sperm extract were assayed for the presence of the other members of the Src family.  
Using this approach we were not able to find the presence of any of the other Src family 
Fig. 10 Concentration dependent effects of Src family inhibitors on the 
appearance of tyrosine phosphorylated proteins in capacitated mouse 
sperm.  Mouse sperm was incubated under conditions that support 
capacitation (+BSA, +NaHCO3) or not (-BSA, -NaHCO3).  Incubation 
reaction was carried away in the presence or absence of increasing 
concentrations of SU6656 or SKI606. Total mouse sperm extracts (~ 2 x 106 
cells) were lysed in sample buffer and separated by 10 % SDS-PAGE and 
transferred to Inmobilon P. Western blots were performed using anti-
phosphotyrosine (α-pY) antibody.  This experiment was performed at least 
three times with similar results. Shown is a representative experiment. 
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members.  These results suggest that Src is the kinase that is being inhibited by the 
inhibitor SU6656 and SKI606.  
 
 
 
 
 
 
 
 
Fig.11. Src kinase is present in mouse sperm extract.  Total mouse sperm 
extracts (~ 2 x 106 cells) were lysed in sample buffer or extracted in RIPA buffer,  
separated by 10 % SDS-PAGE and transferred to Inmobilon P. Western blots were 
performed using anti-Src, anti-fyn, anti- lck, anti- lyn, anti- blk, anti- yes, anti- hck 
and anti-fgr antibodies. Experiments shown are representative of experiments 
performed at least three times with similar results.	   	   In the rightmost lane 20 µg of 
the respective positive control was run in parallel.  A representative of three 
repetitions is shown.  Abbreviations: MACS (Mouse macrophages); NAM 
(namalwa cells); MDCK (Madin-Darby canine kidney); spleen (mouse spleen 
extract).  Membranes were reblotted with anti-actin as a loading control. 
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Src activity in mouse sperm 
Since we were able to observe a inhibitory effect on the tyrosine phosphorylation 
normally correlated with the capacitated sperm state when sperm were incubated in the 
presence of Src inhibitors, we decided to analyze whether there is a change in Src activity 
levels during capacitation. We measured the kinase activity using the well characterized 
Src peptidic substrate cdc2 (KVEKIGEGTYGVVYK).   
 
 
 
 
 
 
 
 
Fig.12. Src kinase activity in non capacitated and capacitated mouse sperm.   
Mouse cauda sperm was incubated in conditions that elicit (+BSA, +NaHCO3), 
or not capacitation and extracted as described in “Material and Methods” A) 
Mouse sperm extracts were incubated with anti-Src (GD11) antibody for 2 hr.  
Protein G Sepharose was added for another h.  Sepharose beads were then 
washed three times with the same buffer and proteins bound were eluted from 
the beads by boiling. Immunoprecipitated proteins were then separated by 10% 
gel, transferred and then probed with anti- Src antibody (36D10).  Anti-tubulin 
antibody was used as a control.  As a second control sperm extracts were 
incubated with beads without antibody.   B) Posterior to incubation with anti-
Src (GD11) antibody, proteins were immunoprecipitated and subjected to a 
kinase reaction using cdc2 as a substrate.  The incorporation of 32P (nmol) per 
minute per 5 million sperm cells was assayed by scintillation counting. C)  
Sample as in B was separated by 8% gel, transferred and 32P  was visualized by 
autoradiography.  Same membrane was probed with anti-Src antibody.  Results 
illustrate one of three replicated performed experiments. 
A B C 
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Sperm were incubated in conditions that support (+ BSA, + NaHCO3) or do not (- BSA, - 
NaHCO3) support capacitation for 60 min.  Src was then isolated from sperm extracts by 
immunoprecipitation using a monoclonal antibody against Src (GD11).  The immuno 
precipitate was incubated in a kinase buffer containing 32ATP and the specific substrate 
(cdc2).  As shown in Fig. 12, Src activity was significantly higher in capacitated sperm 
than in the non capacitated sperm. In addition to the effect of Src inhibitors on the 
phosphorylation state of sperm proteins, this observation points toward an active role of 
Src during sperm capacitation   
Specificity of Src inhibitors 
In order to discard possible nonspecific effects of SU6656 and SKI606 on other 
kinases than Src kinase, we analyzed the effect of these inhibitors on PKA activity. PKA 
is a known player of capacitating pathway. Moreover, it has been recently suggested that 
in mouse sperm, Src lies downstream of PKA in the signaling pathway that leads to the 
phosphorylation of sperm proteins (Baker et al. 2006). With this hypothesis in mind, 
SU6656 and SKI606 should have no effect on PKA activity. In other to analyze PKA 
activity in vivo, we used a specific monoclonal antibody against phosphor-PKA 
substrates (RRXpS/pT). Sperm protein extracts were prepared following incubating 
conditions that support capacitation; western blots were performed to assay PKA activity 
(Morgan et al. 2008).  To our surprise, in the presence of the same concentration that 
abrogates the capacitation-dependent tyrosine phosphorylation, the inhibitors strongly 
abolishes the phosphorylation of serine/threonine residues of PKA substrates (Fig. 13).  
This striking result suggests that tyrosine phosphorylation is being inhibited due to 
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nonspecific inhibition of PKA. The same effect was observed when specific PKA 
inhibitors were used (not shown).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Should the effect of Src inhibitors on tyrosine phosphorylation be exerted through 
the blockade of PKA activity, PKA should also be inhibited when an in vitro 
kinetic assay are conducted.  To confirm the effect of Src inhibitors on PKA, we 
analyzed vitro PKA activity in the presence of SU6656 and SKI606. Sperm were 
lysed with 1% Triton X-100 in the presence of protease and phosphatase 
inhibitors Then, the reactions were conducted in the presence of cAMP (with the 
phosphodiesterase inhibitor IBMX), and different concentrations of SU6656 or 
Fig. 13. Effects of Src family inhibitors on the appearance of 
phosphorylation of PKA substrates in capacitated mouse sperm.  Mouse 
sperm was incubated under conditions that support capacitation (+BSA, 
+NaHCO3) or not (-BSA, -NaHCO3).  Incubation reaction was performed in 
the presence or absence of 50µM of SU6656 or SKI606. Total mouse sperm 
extracts (~ 2 x 106 cells) were lysed in sample buffer and separated by 10 % 
SDS-PAGE and transferred to Inmobilon P. Western blots were performed 
using an antibody that recognizes phosphorylated PKA substrates.  This 
experiment was performed thrice with similar results. Shown is a 
representative experiment. 
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SKI606.  The well known PKA inhibitor, H-89, was used as a control.  After 30 
min, ATP incorporated to the PKA substrate (kemptide) was estimated using a 
scintillation counter. Surprisingly, no inhibition of PKA activity was found when 
Src inhibitors were present. In light of these results, it is understood that PKA 
activity is indirectly affected by Src inhibitors. It could be then hypothesized that 
Src could be an important player of the capacitating signaling pathway that is 
located upstream of PKA.  
 
 
 
 
 
 
 
 
 
 
Discussion 
 
 One of the missing links in the signaling pathways that lead to sperm capacitation 
is the identity of the tyrosine kinase downstream of PKA.  In terms of temporal regulation 
of capacitation events, PKA mediates both slow and fast events (Salicioni et al. 2007).  
The phosphorylation of tyrosine residues is a slow associated event and is mediated by  a 
crosstalk among PKA and one or several tyrosine kinases(Visconti et al. 1995b).  
Fig. 14.  Effects of Src family inhibitors on PKA activity in vitro.  Mouse 
cauda sperm (~105) were incubated presence of PKA agonist (media 
supplemented + 1 mM db-cAMP, +100 µM IBMX) and increasing 
concentrations of SU6656 and SKI606. Cells were lysed with Triton-X100.  
Incorporation of 32P relative to the sample without inhibitors (100%) is 
shown.   
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Recently, Baker et al (2006) proposed a model in which PKA regulates Src kinase 
activity both directly by phosphorylation of serine 17 and indirectly by inhibition of Src 
inhibitor, Csk.  According to the model, these signaling events will lead to a change in 
the conformation of Src, triggering the autophosphorylation and rendering the enzyme 
active.   
 Src family members had been reported in sperm of several mammalian species, 
using an immunological approach, here we show the presence of Src kinase and the 
absence of the other members of the family.  Likewise, we show the abrogation of the 
capacitation associated tyrosine phosphorylation in the presence of Src family inhibitors.  
Importantly, these inhibitors have been characterized as highly specific for Src and Src 
family members, SU6656 IC50 is reported as 0.28±0.03 µM (Blake et al. 2000) and SKI-
606 reported as 250 nM (Vultur et al. 2008).   Taken together, our results suggest Src 
involvement in the capacitation associated tyrosine phosphorylation. 
 To confirm such results, we performed a Src kinase assay by immunoprecipitating 
Src from sperm incubated in non capacitated and capacitated conducive conditions for 60 
minutes.  Consistent with our results, we found a significant increase in the activity of Src 
in the capacitated sperm.  Baker et al (2006) recently proposed a model in which Src is 
placed downstream of PKA.  In fibroblast cells it has been shown in vivo and in vitro   
(Stork and Schmitt 2002) PKA phosphorylates Src in serine 17, which triggers the 
activation of Src. 
 In sperm capacitation, PKA activation occurs during the first 30 min of 
capacitation (Morgan et al. 2008).  In order to rule out the effect of the inhibitors on PKA 
activity, using the same concentration of SU6656 and SKI-606 that abrogated the 
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tyrosine phosphorylation, we performed a western blot using an antibody that recognizes 
subtrates phosphorylated by PKA.  Unexpectedly, we found that Src inhibitors were 
strongly abolishing the phosphorylation of PKA substrates.   
 To validate this data, we capacitated sperm in the presence of Triton X-100, PKA 
agonists (+dbcA, +IBMX) and Src inhibitor for 30 minutes, and PKA activity was 
assayed.   The activity of PKA in these conditions was not significantly affected by the 
presence of Src inhibitors.  The in vitro assay results are incongruous with the results we 
obtained in the PKA substrates western blot.  PKA activity is regulated by spatial cellular 
distribution that the PKA anchoring proteins provide.  Sperm cells are highly 
compartmelized; therefore, the lack of spatial organization may have affected the activity 
of PKA.   
 Our results suggest a crosstalk between Src and PKA during capacitation.  The 
involvement of PKA signaling as a trigger of tyrosine kinase phosphorylation during 
capacitation is supported by a work from different labs in several mammalian species, 
and  a very accepted model (Visconti and Kopf 1998) suggest a tyrosine kinase 
downstream of PKA.  The identity and the signaling pathways that lead to the increase of 
tyrosine phosphorylation still remain outstanding. 
 In summary, our results suggest that the only Src family present in mouse sperm 
is the first characterized member of the Src family members and its inhibition results in 
abrogation of tyrosine phosphorylation.  We also present evidence that point towards a 
link between Src and PKA, in the regulation of the capacitation associated tyrosine 
phosphorylation. However, our results indicated that Src might be activated either prior 
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or concomitant to PKA activation. Noteworthy, Src inhibitions impairs PKA activity in 
vivo. 
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CHAPTER V 
CONCLUSIONS AND FUTURE DIRECTIONS 
 
Conclusions 
 
 Sperm capacitation correlates with an increase of tyrosine phosphorylation of a 
subset of proteins in several mammalian species (Visconti et al. 1995; Leclerc et al. 1996; 
Galantino-Homer et al. 1997; Kulanand and Shivaji 2001).  The role of the 
phosphorylation signaling in the capacitation events is still unclear.   One   step towards 
the understanding of the possible role of the sperm capacitation associated tyrosine 
phosphorylation is the identification of the proteins that undergo these conserved post 
translational changes.   By separating the phosphoproteins with two dimensional SDS-
PAGE followed by MS/MS, we identified: tubulin, VDAC, PDH E1 β chain, glutathione 
S-transferase, NADH dehydrogenase (ubiquinone) Fe-S protein 6, acrosin binding 
protein precursor, proteasome subunit alpha type 6b, and cytochrome b-c1 complex as 
tyrosine phosphoproteins upon mouse sperm capacitation.  Of such proteins, we focused 
on characterizing those that are involved in the glycolytic and cellular respiration 
pathway, due to the expected high requirement for ATP of sperm during capacitation 
events.  We showed the presence by western blot and immunofluorescence of VDAC, 
Pyruvate dehydrogenase E1 β chain, found in the midpiece.  Likewise, we found aldolase 
in the principal piece. 
 Two isoforms of aldolase were identified as phosphoproteins associated with 
capacitation: aldoart1and aldoart2.  These two isoforms have been recently reported 
(Vemuganti et al. 2007) in mouse sperm as two testis specific intronless genes, most 
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likely, retrotrasposons ( Aldoart1 in chromosome 4 and Aldoart2 in chromosome 12).  
Two additional isoforms of aldolase are splicing variants of the somatic AldoA.  
Althought we could not detect a significant difference in the activity of aldolase by 
fluorimetry upon capacitation, it cannot be discarded a possible role in the capacitation 
events.   
 The signaling events that bring about the tyrosine phosphorylation increase upon 
capacitation are far from being elucidated (Salicioni et al. 2007).  Early on the 
capacitation events is the influx of HCO3- One of the likely targets of HCO3-  is the 
unique soluble adenylyl cyclase that will bring about the increase of cyclic AMP 
(reviewed by Salicioni et al., 2007).  In sperm the best characterized effector is the 
serine/threonine kinase PKA.  The increase of PKA activity proposed to be the first step 
of following tyrosine kinase cascade activation.  Here we show that Src is the only 
member of the Src family of kinases present in sperm. 
We show that the use of specific inhibitors abrogates the tyrosine phosphorylation 
associated with capacitation.  Moreover, the activity of the Src kinase during capacitation   
increases significantly.  However, the activity of PKA, as determined using a specific 
antibody that recognized the serine/threonine phosphoproteins was inhibited by both Src 
inhibitors, SU6656 and SKI-606 at a 50 µM concentration.  The in vitro activity of PKA, 
unexpectedly, not affected in the presence of SU6656 or SKI-606.  Our results suggest an 
involvement of a crosstalk between Src and PKA activities in capacitation associated 
events.  
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Future Directions 
    
 Future studies will focus in the characterization of the tyrosine phosphoproteins 
that we identified.  This information is crucial to the understanding of the biological 
relevance of tyrosine phosphorylation in capacitation events.  We speculate that the 
proteins involved in the production of ATP; glycolytic and electron chain transport 
pathways (VDAC, PDH E1 β chain,  NADH dehydrogenase (ubiquinone) Fe-S protein 6 
and cytochrome b-c1) role is critical for capacitation and we expect that the change of the 
phosphorylation status mediates the activity level.  Tubulin has been shown (Ficarro et al. 
2003) to be tyrosine phosphorylated upon capacitation as well, the exact role is still 
unclear.  The function of glutathione S-transferase, acrosin binding protein precursor, 
proteasome subunit alpha type 6b need as well to be elucidated. 
 Looking upstream on the regulation of the tyrosine kinase(s) that bring about the 
tyrosine phosphorylation, our results suggest a crosstalk between Src tyrosine kinase and 
PKA.  The activity of Src might be upstream of the activation of PKA.  This findings 
report the first tyrosine kinase in sperm that regulates a key step of capacitation events.  
Further studies will focus on the identification of the molecules that mediate that 
crosstalk and its regulation.  
 50 
 
BIBLIOGRAPHY 
 
 
Aitken RJ, Harkiss D, Knox W, Paterson M, Irvine DS (1998) A novel signal 
transduction cascade in capacitating human spermatozoa characterised by a 
redox-regulated, cAMP-mediated induction of tyrosine phosphorylation. J Cell 
Sci 111(Pt 5): 645-656. 
 
Austin CR (1951) Activation and the correlation between male and female elements in 
fertilization. Nature 168(4274): 558-559. 
 
Austin CR (1952) The capacitation of the mammalian sperm. Nature 170(4321): 326. 
 
Baker MA, Hetherington L, Aitken RJ (2006) Identification of SRC as a key PKA-
stimulated tyrosine kinase involved in the capacitation-associated hyperactivation 
of murine spermatozoa. J Cell Sci 119(Pt 15): 3182-3192. 
 
Bergmeyer HU (1974) Methods of enzymatic analysis: New York Academic Press, New 
 York430 p. 
 
Bishop JM, Baker B, Fujita D, McCombe P, Sheiness D et al. (1978) Genesis of a virus-
transforming gene. Natl Cancer Inst Monogr(48): 219-223. 
 
 51 
Blake RA, Broome MA, Liu X, Wu J, Gishizky M et al. (2000) SU6656, a selective src 
family kinase inhibitor, used to probe growth factor signaling. Mol Cell Biol 
20(23): 9018-9027. 
 
Blomberg A (1997) Osmoresponsive proteins and functional assessment strategies in 
Saccharomyces cerevisiae. Electrophoresis 18(8): 1429-1440. 
 
Bordeleau LJ, Leclerc P (2008) Expression of hck-tr, a truncated form of the src-related 
tyrosine kinase hck, in bovine spermatozoa and testis. Mol Reprod Dev 75(5): 
828-837. 
 
Chang MC (1951) Fertilizing capacity of spermatozoa deposited into the fallopian tubes. 
Nature 168(4277): 697-698. 
 
Collett MS, Erikson RL (1978) Protein kinase activity associated with the avian sarcoma 
virus src gene product. Proc Natl Acad Sci U S A 75(4): 2021-2024. 
 
Coluccia AM, Benati D, Dekhil H, De Filippo A, Lan C et al. (2006) SKI-606 decreases 
growth and motility of colorectal cancer cells by preventing pp60(c-Src)-
dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling. 
Cancer Res 66(4): 2279-2286. 
 
 52 
Ecroyd H, Jones RC, Aitken RJ (2003) Tyrosine phosphorylation of HSP-90 during 
mammalian sperm capacitation. Biol Reprod 69(6): 1801-1807. 
 
Ficarro S, Chertihin O, Westbrook VA, White F, Jayes F et al. (2003) Phosphoproteome 
analysis of human sperm. Evidence of tyrosine phosphorylation of AKAP 3 and 
valosin containing protein/P97 during capacitation. J Biol Chem 278(13): 11579-
11589. 
 
Gadella BM, Harrison RA (2000) The capacitating agent bicarbonate induces protein 
kinase A-dependent changes in phospholipid transbilayer behavior in the sperm 
plasma membrane. Development 127(11): 2407-2420. 
 
Galantino-Homer HL, Visconti PE, Kopf GS (1997) Regulation of protein tyrosine 
phosphorylation during bovine sperm capacitation by a cyclic adenosine 3'5'-
monophosphate-dependent pathway. Biol Reprod 56(3): 707-719. 
 
Harrison RA (1996) Capacitation mechanisms, and the role of capacitation as seen in 
eutherian mammals. Reprod Fertil Dev 8(4): 581-594. 
 
Harrison RA, Miller NG (2000) cAMP-dependent protein kinase control of plasma 
membrane lipid architecture in boar sperm. Mol Reprod Dev 55(2): 220-228. 
 
 53 
Harrison DA, Carr DW, Meizel S (2000) Involvement of protein kinase A and A kinase 
anchoring protein in the progesterone-initiated human sperm acrosome reaction. 
Biol Reprod 62(3): 811-820. 
 
Ingley E (2008) Src family kinases: regulation of their activities, levels and identification 
of new pathways. Biochim Biophys Acta 1784(1): 56-65. 
 
Jha KN, Shivaji S (2002) Identification of the major tyrosine phosphorylated protein of 
capacitated hamster spermatozoa as a homologue of mammalian sperm a kinase 
anchoring protein. Mol Reprod Dev 61(2): 258-270. 
 
Kierszenbaum AL, Rivkin E, Talmor-Cohen A, Shalgi R, Tres LL (2009) Expression of 
full-length and truncated Fyn tyrosine kinase transcripts and encoded proteins 
during spermatogenesis and localization during acrosome biogenesis and 
fertilization. Mol Reprod Dev 76(9): 832-843. 
 
Kulanand J, Shivaji S (2001) Capacitation-associated changes in protein tyrosine 
phosphorylation, hyperactivation and acrosome reaction in hamster spermatozoa. 
Andrologia 33(2): 95-104. 
 
Kumar V, Kota V, Shivaji S (2008) Hamster sperm capacitation: role of pyruvate 
dehydrogenase A and dihydrolipoamide dehydrogenase. Biol Reprod 79(2): 190-
199. 
 54 
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227(259): 680-685 
 
Lalancette C, Faure RL, Leclerc P (2006a) Identification of the proteins present in the 
bull sperm cytosolic fraction enriched in tyrosine kinase activity: a proteomic 
approach. Proteomics 6(16): 4523-4540. 
 
Lalancette C, Bordeleau LJ, Faure RL, Leclerc P (2006b) Bull testicular haploid germ 
cells express a messenger encoding for a truncated form of the protein tyrosine 
kinase HCK. Mol Reprod Dev 73(4): 520-530. 
 
Lawson C, Goupil S, Leclerc P (2008) Increased activity of the human sperm tyrosine 
kinase SRC by the cAMP-dependent pathway in the presence of calcium. Biol 
Reprod 79(4): 657-666. 
 
Leclerc P, de Lamirande E, Gagnon C (1996) Cyclic adenosine 3',5'monophosphate-
dependent regulation of protein tyrosine phosphorylation in relation to human 
sperm capacitation and motility. Biol Reprod 55(3): 684-692. 
 
Leclerc P, Goupil S (2002) Regulation of the human sperm tyrosine kinase c-yes. 
Activation by cyclic adenosine 3',5'-monophosphate and inhibition by Ca(2+). 
Biol Reprod 67(1): 301-307. 
 
 55 
Mandal A, Naaby-Hansen S, Wolkowicz MJ, Klotz K, Shetty J et al. (1999) FSP95, a 
testis-specific 95-kilodalton fibrous sheath antigen that undergoes tyrosine 
phosphorylation in capacitated human spermatozoa. Biol Reprod 61(5): 1184-
1197. 
 
Martin GS (1970) Rous sarcoma virus: a function required for the maintenance of the 
transformed state. Nature 227(5262): 1021-1023. 
 
Mitchell LA, Nixon B, Baker MA, Aitken RJ (2008) Investigation of the role of SRC in 
capacitation-associated tyrosine phosphorylation of human spermatozoa. Mol 
Hum Reprod 14(4): 235-243. 
 
Mitra K, Shivaji S (2004) Novel tyrosine-phosphorylated post-pyruvate metabolic 
enzyme, dihydrolipoamide dehydrogenase, involved in capacitation of hamster 
spermatozoa. Biol Reprod 70(4): 887-899. 
 
Moore GD, Ayabe T, Visconti PE, Schultz RM, Kopf GS (1994) Roles of heterotrimeric 
and monomeric G proteins in sperm-induced activation of mouse eggs. 
Development 120(11): 3313-3323. 
 
Morgan DJ, Weisenhaus M, Shum S, Su T, Zheng R et al. (2008) Tissue-specific PKA 
inhibition using a chemical genetic approach and its application to studies on 
sperm capacitation. Proc Natl Acad Sci U S A. 
 56 
 
Naaby-Hansen S, Flickinger CJ, Herr JC (1997) Two-dimensional gel electrophoretic 
analysis of vectorially labeled surface proteins of human spermatozoa. Biol 
Reprod 56(3): 771-787. 
 
Naaby-Hansen S, Mandal A, Wolkowicz MJ, Sen B, Westbrook VA et al. (2002) 
CABYR, a novel calcium-binding tyrosine phosphorylation-regulated fibrous 
sheath protein involved in capacitation. Dev Biol 242(2): 236-254. 
 
Nagdas SK, Winfrey VP, Olson GE (2005) Tyrosine Phosphorylation Generates Multiple 
Isoforms of the Mitochondrial Capsule Protein, Phospholipid Hydroperoxide 
Glutathione Peroxidase (PHGPx), During Hamster Sperm Capacitation. Biol 
Reprod 72(1): 164-171. 
 
Racker E (1947) Spectrophotometric measurement of hexokinase and phosphohexokinase 
activity. The Journal of Biological Chemistry 167: 843-854. 
 
Salicioni AM, Platt MD, Wertheimer EV, Arcelay E, Allaire A et al. (2007) Signalling 
pathways involved in sperm capacitation. Soc Reprod Fertil Suppl 65: 245-259. 
 
Schartl M, Barnekow A (1982) The expression in eukaryotes of a tyrosine kinase which 
is reactive with pp60v-src antibodies. Differentiation 23(2): 109-114. 
 
 57 
Stork PJ, Schmitt JM (2002) Crosstalk between cAMP and MAP kinase signaling in the 
regulation of cell proliferation. Trends Cell Biol 12(6): 258-266 
 
Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu 
Rev Cell Dev Biol 13: 513-609. 
 
Varano G, Lombardi A, Cantini G, Forti G, Baldi E et al. (2008) Src activation triggers 
capacitation and acrosome reaction but not motility in human spermatozoa. Hum 
Reprod 23(12): 2652-2662. 
 
Visconti PE, Bailey JL, Moore GD, Pan D, Olds-Clarke P et al. (1995) Capacitation of 
mouse spermatozoa. I. Correlation between the capacitation state and protein 
tyrosine phosphorylation. Development 121(4): 1129-1137. 
 
Visconti PE, Moore GD, Bailey JL, Leclerc P, Connors SA et al. (1995) Capacitation of 
mouse spermatozoa. II. Protein tyrosine phosphorylation and capacitation are 
regulated by a cAMP-dependent pathway. Development 121(4): 1139-1150. 
 
Visconti PE, Moore GD, Bailey JL, Leclerc P, Connors SA et al. (1995b) Capacitation of 
mouse spermatozoa. II. Protein tyrosine phosphorylation and capacitation are 
regulated by a cAMP-dependent pathway. Development 121(4): 1139-1150. 
 
 
 58 
Visconti PE, Johnson LR, Oyaski M, Fornes M, Moss SB et al. (1997) Regulation, 
localization, and anchoring of protein kinase A subunits during mouse sperm 
capacitation. Dev Biol 192(2): 351-363. 
 
Visconti PE, Kopf GS (1998) Regulation of protein phosphorylation during sperm 
capacitation. Biol Reprod 59(1): 1-6. 
 
Visconti PE, Stewart-Savage J, Blasco A, Battaglia L, Miranda P et al. (1999) Roles of 
bicarbonate, cAMP, and protein tyrosine phosphorylation on capacitation and the 
spontaneous acrosome reaction of hamster sperm. Biol Reprod 61(1): 76-84. 
 
Visconti PE, Westbrook VA, Chertihin O, Demarco I, Sleight S et al. (2002) Novel 
signaling pathways involved in sperm acquisition of fertilizing capacity. J Reprod 
Immunol 53(1-2): 133-150. 
 
Visconti PE (2009) Understanding the molecular basis of sperm capacitation through 
kinase design. Proc Natl Acad Sci U S A 106(3): 667-668. 
 
Yanagimachi R (1994) Mammalian fertilization. In: Knobil E, Neill JD, editors. The 
Physiology of Reproduction. New York: Raven Press, Ltd. pp. 189-317. 
 
 
 
